ICML 2025: Combining Radiation and Bispecific Antibodies in Blood Cancer
A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can be safely integrated with bispecific antibody treatment in patients with relapsed or refractory blood cancers…